Ms contin and Tenosynovitis stenosans - a phase IV clinical study of FDA data

Summary:

Tenosynovitis stenosans is reported as a side effect among people who take Ms contin (morphine sulfate), especially for people who are female, 60+ old, also take Zometa, and have Metastases to bone.

The phase IV clinical study analyzes which people have Tenosynovitis stenosans when taking Ms contin. It is created by eHealthMe based on reports of 68,873 people who have side effects when taking Ms contin from the FDA, and is updated regularly.

What is Ms contin?

Ms contin has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 69,289 Ms contin users. Check the latest studies of Ms contin.

What is Tenosynovitis stenosans?

Tenosynovitis stenosans (a common disorder characterized by catching, snapping or locking of the involved finger flexor tendon, associated with dysfunction and pain) is found to be associated with 247 drugs and 307 conditions by eHealthMe. Check the latest studies of Tenosynovitis stenosans.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 14, 2026

68,873 people reported to have side effects when taking Ms contin.
Among them, 22 people (0.03%) have Tenosynovitis stenosans.

Could Ms contin cause Tenosynovitis stenosans?

Among these 22 people:

What is the gender of people who have Tenosynovitis stenosans when taking Ms contin? *

female: 81.82 %
male: 18.18 %

What is the age of people who have Tenosynovitis stenosans when taking Ms contin? *

What are other drugs people take besides Ms contin? *

What are other side effects people have besides Tenosynovitis stenosans? *

Osteonecrosis Of Jaw (death of bone of jaw): 20 people, 90.91%
Stress And Anxiety: 20 people, 90.91%
Depression: 19 people, 86.36%
Intervertebral Disc Degeneration (spinal disc degeneration): 18 people, 81.82%
Constipation: 18 people, 81.82%
Spinal Osteoarthritis (joint cartilage loss in spine): 17 people, 77.27%
Hypoaesthesia (reduced sense of touch or sensation): 17 people, 77.27%
Vertebral Foraminal Stenosis (narrowing of the intervertebral foramen): 16 people, 72.73%
Intervertebral Disc Protrusion (spinal disc protrusion): 16 people, 72.73%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 15 people, 68.18%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 15 people, 68.18%
Breast Cancer: 8 people, 36.36%
Osteomyelitis (infection of bone): 4 people, 18.18%
Breast Cancer Metastatic: 4 people, 18.18%
Bone Cancer Metastatic: 4 people, 18.18%
Stress And Anxiety: 2 people, 9.09%
Weight Loss: 1 person, 4.55%
Psychotic Disorder: 1 person, 4.55%
Osteoporosis (bones weak and more likely to break): 1 person, 4.55%
Oesophagitis (inflammation of oesophagus): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Ms contin and have Tenosynovitis stenosans?

- Check whether Tenosynovitis stenosans is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ms contin:

Ms contin (69,289 reports)

Browse all side effects of Ms contin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tenosynovitis stenosans:

Tenosynovitis stenosans (247 drugs)

Browse all the conditions that are associated with Tenosynovitis stenosans:

Tenosynovitis stenosans (307 conditions)

Related publications that referenced our studies

Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on morphine sulfate (the active ingredients of Ms contin) and Ms contin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.